Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Gary Deutsch

Surgical Oncology Lake Success, NY Medical Doctor

NPI 1073776183 CMS profile 1341831

450 Lakeville Road, Lake Success, NY 10042

Open in the dashboard

General payments

$12,312

39 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$25,050 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Gary Deutsch of Lake Success, NY is reported in the CMS Open Payments database as having received $12,312 across 39 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $25,050 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 87th percentile of Surgical Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,097 16
2024 General $904 4
2023 General $4,106 18
2022 General $204 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gary Deutsch
  • Surgical Oncology median
  • Middle half of Surgical Oncology
  • National median

In program year 2025, general payments to Gary Deutsch were reported at $7,097. Among 1,137 Surgical Oncology profiles paid that year, the median was $288 and the middle half received between $118 and $1,346.

Show as a table
Year Gary Deutsch Surgical Oncology median Middle half National median
2019 $0 $236 $86–$1,064 $163
2020 $0 $130 $47–$648 $114
2021 $0 $160 $53–$943 $132
2022 $204 $199 $76–$782 $149
2023 $4,106 $246 $95–$854 $160
2024 $904 $271 $106–$1,123 $164
2025 $7,097 $288 $118–$1,346 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Intuitive Surgical, Inc. $11,676 30 payments
  2. AngioDynamics, Inc. $204 1 payment
  3. Dilon Technologies, Inc. $148 1 payment
  4. Integra LifeSciences Corporation $136 1 payment
  5. AbbVie, Inc. $98 4 payments
  6. Davol Inc. $25 1 payment
  7. Histosonics, Inc. $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Education $7,500 3 payments
  2. Travel and Lodging $3,295 18 payments
  3. Food and Beverage $1,517 18 payments
Products named General payments · program years 2022–2025
  1. Da Vinci Surgical System $10,176 29 payments
  2. DA VINCI SP $1,500 1 payment
  3. NANOKNIFE $204 1 payment
  4. HEMOBLAST BELLOWS $148 1 payment
  5. CODMAN CERTAS $136 1 payment
  6. CUSA CLARITY $136 1 payment
  7. CODMAN HAKIM $136 1 payment
  8. DURASEAL EXACT SPINAL SEALANT SYSTEM $136 1 payment
  9. CREON $98 4 payments
  10. Phasix Mesh $25 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$103,468

Medicare's payments for the services billed

Medicare patients

160

Average age 76

Services billed

337

91 women, 69 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 62%
Ischemic heart disease 46%
Diabetes 44%
Chronic kidney disease 31%
Cancer 31%
COPD 24%
Atrial fibrillation 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

39 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgical Oncology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record